Cargando…
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin, and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or acquired resistance severely limit the clinical application of platinum-based treatment. The underlying mechanisms are i...
Autores principales: | Zhou, Jiabei, Kang, Yu, Chen, Lu, Wang, Hua, Liu, Junqing, Zeng, Su, Yu, Lushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100275/ https://www.ncbi.nlm.nih.gov/pubmed/32265714 http://dx.doi.org/10.3389/fphar.2020.00343 |
Ejemplares similares
-
The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma
por: Lu, Enzhou, et al.
Publicado: (2022) -
Non-coding RNA-related antitumor mechanisms of marine-derived agents
por: Zhou, Zhixia, et al.
Publicado: (2022) -
Research and development of drug delivery systems based on drug transporter and nano-formulation
por: Peng, Yi, et al.
Publicado: (2020) -
Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs
por: Qin, Zhiying, et al.
Publicado: (2020) -
Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
por: Mondal, Priya, et al.
Publicado: (2023)